Demers R Y, Severson R K, Schottenfeld D, Lazar L
Cancer Center, Henry Ford Health System, Detroit, Michigan, USA.
Cancer. 1997 Feb 1;79(3):441-7. doi: 10.1002/(sici)1097-0142(19970201)79:3<441::aid-cncr3>3.0.co;2-l.
Colorectal adenocarcinoma may represent more than one disease process. Numerous epidemiologic studies suggest that rates of occurrence of colorectal adenocarcinoma at particular anatomic subsites (e.g., right colon, left colon, and rectum) may be associated with distinctive geographic, demographic, and risk factor profiles. This study explored time trends over a 22-year period of the incidence of adenocarcinoma of the colon and rectum at various subsites among patients of different race, gender, and stage of disease.
Data on the incidence of colorectal adenocarcinoma were obtained from a population-based cancer registry in the Detroit, Michigan area funded by the National Cancer Institute. Age-adjusted incidence rates were analyzed by year of diagnosis. Relative survival rates were also obtained for different race and gender categories, along with disease stage at diagnosis.
A major rise was revealed in the incidence of adenocarcinoma in the right colon among African American men and women between the mid-1970s and the early 1980s. The rise was greatest among African American men and accounts for increases in late stage disease among them. Corresponding decreases in survival among African American men were noted.
These findings indicated widely differing disease patterns based on anatomic subsite and patient demography and also indicated a need for targeted efforts at early detection of adenocarcinoma of the right colon among African Americans.
结直肠癌可能代表不止一种疾病过程。大量流行病学研究表明,结直肠癌在特定解剖亚部位(如右半结肠、左半结肠和直肠)的发生率可能与独特的地理、人口统计学和风险因素特征相关。本研究探讨了在22年期间,不同种族、性别和疾病阶段的患者中,结肠和直肠各亚部位腺癌发病率的时间趋势。
结直肠癌发病率数据来自美国国家癌症研究所资助的密歇根州底特律地区的一项基于人群的癌症登记处。按诊断年份分析年龄调整发病率。还获得了不同种族和性别类别以及诊断时疾病阶段的相对生存率。
20世纪70年代中期至80年代初,非裔美国男性和女性右半结肠腺癌发病率大幅上升。在非裔美国男性中上升幅度最大,且导致他们晚期疾病增加。注意到非裔美国男性的生存率相应下降。
这些发现表明,基于解剖亚部位和患者人口统计学的疾病模式差异很大,也表明需要针对性地努力在非裔美国人中早期检测右半结肠腺癌。